Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BIODRAMINA INFANTIL 12,5 MG SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BIODRAMINA INFANTIL 12,5 MG SOLUCION ORAL

Approved

STANDARD

BIODRAMINA INFANTIL 12,5 MG SOLUCION ORAL

Uriach Consumer Healthcare S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 13, 2021
Approval ID: 295b0c28cf76da71
Company: Uriach Consumer Healthcare S.L.
Type: Standard

Approval Details

Approval Id: 295b0c28cf76da71
Drug Cima Aemps Name: BIODRAMINA INFANTIL 12,5 MG SOLUCION ORAL
Register Number: 85911
Holder Company Name: Uriach Consumer Healthcare S.L.
Marketing Company Name: Uriach Consumer Healthcare S.L.
Authorization Date: 2021-04-13
Dosage Form: SOLUCION ORAL EN SOBRE
Dose: 12.5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Uriach Consumer Healthcare S.L.

Active Ingredients

DIMENHIDRINATO

12,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 13, 2021

Approval ID

295b0c28cf76da71

Type

Standard

Back to CIMA-AEMPS Approvals